{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:58:38Z","timestamp":1787014718396,"version":"build-2736575974"},"reference-count":31,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,1,28]],"date-time":"2009-01-28T00:00:00Z","timestamp":1233100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of the study was to compare the performance of several bedside neuropsychological tools for detection of HIV\u2010associated neurocognitive disorder (HAND) in antiretroviral drug\u2010exposed persons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We analysed the relative performance of the HIV Dementia Scale (HDS), International HIV Dementia Scale (IHDS) and the Mini\u2010Mental Status Exam (MMSE) together with neuropsychological tests (Symbol\u2010Digit, Grooved Pegboard and Trail Making) in HIV\u20101\u2010seronegative subjects (HIV\u2212;\n                      <jats:italic>n<\/jats:italic>\n                      =13) and in HIV\u20101\u2010seropositive subjects with HAND (HIV+HAND;\n                      <jats:italic>n<\/jats:italic>\n                      =13) and other neurological disorders (HIV+OND;\n                      <jats:italic>n<\/jats:italic>\n                      =20).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Established neuropsychological tests consistently showed significantly poorer performance by HIV+HAND subjects compared with the other two groups. Similarly, the mean HDS and IHDS scores were lower in the HIV+HAND group compared with the other two groups (\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.005) while the mean MMSE score did not show significant differences between the HIV+HAND and HIV+OND groups. Receiver operator characteristics curves generated from these data using predefined cut\u2010off scores revealed that the HDS, IHDS and MMSE displayed corresponding area under the curve values of 0.82, 0.74 and 0.48, respectively (\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.006).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The present findings indicate that the MMSE is a weak tool for diagnosing HAND in this group of patients but the HDS and IHDS demonstrate better efficiencies, although cut\u2010off values for the HDS require reassessment in the era of effective antiretroviral therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1468-1293.2008.00679.x","type":"journal-article","created":{"date-parts":[[2009,1,27]],"date-time":"2009-01-27T22:27:08Z","timestamp":1233095228000},"page":"246-252","source":"Crossref","is-referenced-by-count":77,"title":["Neurocognitive screening tools in HIV\/AIDS: comparative performance among patients exposed to antiretroviral therapy"],"prefix":"10.1111","volume":"10","author":[{"given":"S","family":"Skinner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AJ","family":"Adewale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"DeBlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MJ","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,11]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"World Health Organization.\u20183 by 5\u2019 Progress Report December 2004. World Health Organization and Joint United Nations Programme on HIV\/AIDS 2004."},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100003978"},{"key":"e_1_2_6_4_2","first-page":"2005","article-title":"Neuropsychiatric disorders in HIV infection","volume":"20","author":"Yeung H","year":"2006","journal-title":"impact of diagnosis on economic costs of care"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000287431.88658.8b"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/13550280290101094"},{"key":"e_1_2_6_7_2","first-page":"e13","article-title":"Factors in AIDS dementia complex trial design","volume":"2","author":"Brew BJ","year":"2007","journal-title":"results and lessons from the abacavir trial"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.68.7.4643-4649.1994"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1997.00550160054016"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.3.645"},{"key":"e_1_2_6_11_2","first-page":"33","article-title":"HIV and antiretroviral therapy in the brain","volume":"8","author":"Ellis R","year":"2007","journal-title":"neuronal injury and repair"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617704102130"},{"key":"e_1_2_6_13_2","first-page":"8","article-title":"Neuropsychological impairment in human immunodeficiency virus infection","volume":"56","author":"Heaton RK","year":"1994","journal-title":"implications for employment. HNRC Group. HIV Neurobehavioral Research Center"},{"issue":"1","key":"e_1_2_6_14_2","first-page":"S19","article-title":"Medication adherence in HIV\u2010infected adults","volume":"18","author":"Hinkin CH","year":"2004","journal-title":"effect of patient age, cognitive status, and substance abuse"},{"key":"e_1_2_6_15_2","first-page":"40","article-title":"Age\u2010associated predictors of medication adherence in HIV\u2010positive adults","volume":"26","author":"Barclay TR","year":"2007","journal-title":"health beliefs, self-efficacy, and neurocognitive status"},{"key":"e_1_2_6_16_2","first-page":"273","article-title":"HIV Dementia Scale","volume":"8","author":"Power C","year":"1995","journal-title":"a rapid screening test"},{"key":"e_1_2_6_17_2","first-page":"1367","article-title":"The International HIV Dementia Scale","volume":"19","author":"Sacktor NC","year":"2005","journal-title":"a new rapid screening test for HIV dementia"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-10-199311150-00006"},{"key":"e_1_2_6_19_2","first-page":"134","article-title":"Validity of two scales in identifying HIV\u2010associated dementia","volume":"21","author":"Berghuis JP","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000008112"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.2466\/PMS.73.5.539-550"},{"key":"e_1_2_6_22_2","first-page":"25","article-title":"Treatment interruption strategies","volume":"21","author":"Paton NI.","year":"2008","journal-title":"how great are the risks?"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.5.1247"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"e_1_2_6_25_2","first-page":"837","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves","volume":"44","author":"DeLong ER","year":"1988","journal-title":"a nonparametric approach"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470317082"},{"key":"e_1_2_6_27_2","first-page":"92","article-title":"HIV\u20101\u2010associated dementia","volume":"22","author":"Power C","year":"1995","journal-title":"clinical features and pathogenesis"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2007.12.027"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2006.0180"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1080\/13803390701233865"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/13550280500516500"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.17.2.185"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2008.00679.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2008.00679.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T11:24:13Z","timestamp":1696850653000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2008.00679.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,11]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1468-1293.2008.00679.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2008.00679.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,11]]}}}